Yao-Chang Chen Selected Research

ITI-214

9/2021

Effects of phosphodiesterase-1 inhibitor on pulmonary vein electrophysiology and arrhythmogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yao-Chang Chen Research Topics

Disease

39	Atrial Fibrillation 01/2022 - 01/2004
16	Heart Failure 09/2021 - 01/2010
12	Fibrosis (Cirrhosis) 01/2022 - 01/2011
8	Inflammation (Inflammations) 01/2022 - 04/2007
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2015 - 02/2003
6	Atrial Remodeling 02/2021 - 07/2009
5	Neoplasms (Cancer) 01/2018 - 05/2003
4	Cardiomyopathies (Cardiomyopathy) 04/2022 - 01/2016
4	Chronic Renal Insufficiency 12/2021 - 07/2017
4	Necrosis 11/2019 - 08/2010
4	Diabetes Mellitus 04/2019 - 09/2014
4	Stroke (Strokes) 10/2018 - 12/2012
3	Tachycardia (Tachyarrhythmias) 01/2020 - 07/2009
3	Body Weight (Weight, Body) 01/2018 - 10/2011
3	Cardiac Arrhythmias (Arrythmia) 12/2016 - 09/2004
3	Leukemia 01/2015 - 02/2003
3	Hypertension (High Blood Pressure) 01/2014 - 10/2011
2	Atrial Premature Complexes (Premature Atrial Contraction) 01/2022 - 01/2020
2	Pericarditis 11/2021 - 10/2018
2	Breast Neoplasms (Breast Cancer) 07/2020 - 05/2003
2	Hyponatremia 09/2019 - 03/2016
2	Infections 01/2019 - 07/2006
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 09/2003
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2016 - 09/2003
2	Atherosclerosis 05/2015 - 12/2010
2	Disease Progression 02/2015 - 02/2014
2	Multiple Myeloma 08/2014 - 09/2003
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2014 - 09/2007
2	Thrombosis (Thrombus) 12/2012 - 09/2003
2	Glioma (Gliomas) 04/2011 - 04/2010
2	Hyperthyroidism 09/2007 - 01/2002
1	Heart Injuries 04/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2019
1	Lung Injury 10/2019
1	Hepatitis 01/2019

Drug/Important Bio-Agent (IBA)

17	CalciumIBA 12/2021 - 04/2007
5	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016 - 08/2010
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2011
4	SodiumIBA 11/2019 - 12/2011
4	Protein Isoforms (Isoforms)IBA 01/2016 - 08/2010
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2020 - 09/2011
3	CytokinesIBA 01/2020 - 04/2007
3	Biological ProductsIBA 10/2018 - 04/2010
3	Histone Deacetylases (Histone Deacetylase)IBA 10/2018 - 06/2016
3	3- (1- benzenesulfonyl- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA 10/2018 - 01/2016
3	Angiotensin IIIBA 12/2016 - 01/2006
3	HLA-DR Antigens (HLA-DR)IBA 01/2015 - 05/2009
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2010 - 04/2007
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2020
2	Pharmaceutical PreparationsIBA 07/2020 - 09/2011
2	HydrogenIBA 04/2019 - 01/2018
2	Proteinase-Activated ReceptorsIBA 10/2018 - 12/2012
2	RivaroxabanIBA 10/2018 - 03/2013
2	Factor Xa InhibitorsIBA 10/2018 - 08/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2018 - 01/2016
2	Blood Glucose (Blood Sugar)IBA 01/2018 - 01/2016
2	Histone Deacetylase InhibitorsIBA 01/2018 - 01/2016
2	Ethanol (Ethyl Alcohol)IBA 01/2018 - 01/2004
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 07/2017 - 12/2016
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 09/2014
2	Colchicine FDA LinkGeneric 01/2016 - 10/2014
2	Ion Channels (Ion Channel)IBA 05/2015 - 10/2014
2	Thalidomide (Thalomid)FDA Link 08/2014 - 09/2003
2	CollagenIBA 06/2013 - 01/2011
2	Rosiglitazone (Avandia)FDA Link 05/2013 - 10/2011
2	ferumoxides (Feridex)FDA Link 04/2011 - 06/2010
1	CeramidesIBA 04/2022
1	Recombinant ProteinsIBA 01/2022
1	AntibodiesIBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	EnzymesIBA 09/2021
1	ITI-214IBA 09/2021
1	Advanced Glycation End ProductsIBA 02/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2021
1	Trastuzumab (Herceptin)FDA Link 07/2020
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 04/2020
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2020
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2020
1	2- (2- (4- (4- nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateIBA 01/2020
1	KN 93IBA 01/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	Macrophage Migration-Inhibitory FactorsIBA 01/2020
1	Cyclic NucleotidesIBA 01/2020
1	sodium bisulfide (NaHS)IBA 11/2019
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 10/2019
1	Phosphoinositide Phospholipase CIBA 10/2019
1	Complement System Proteins (Complement)IBA 10/2019
1	Arginine Vasopressin (Argipressin)IBA 09/2019
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 09/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2019
1	empagliflozinIBA 04/2019
1	Surface Antigens (Surface Antigen)IBA 01/2019

Therapy/Procedure

4	Microelectrodes 11/2021 - 02/2012
3	Hematopoietic Stem Cell Transplantation 11/2016 - 09/2007
3	Ligation 01/2016 - 10/2013
3	Transplantation 11/2014 - 09/2007
3	Therapeutics 12/2011 - 07/2006
2	Drug Therapy (Chemotherapy) 01/2004 - 02/2003